MONITORING AND EVALUATION PLAN

Similar documents
Strategy of TB laboratories for TB Control Program in Developing Countries

TB CONTROL STRATEGIC PLAN FOR GHANA

Dyah Erti Mustikawati

Epidemiological review of TB disease in Sierra Leone

Public Private Mix sub group meeting 23 October, 2011 Scale up PPM in Myanmar

FEDERAL MINISTRY OF HEALTH DEPARTMENT OF PUBLIC HEALTH. National Tuberculosis and Leprosy Control Programme. A Tuberculosis Infection Control Strategy

Programmatic Management of MDR-TB in China: Progress, Plan and Challenge

WHO/HTM/TB/ Task analysis. The basis for development of training in management of tuberculosis

Engagement of Workplace in TB Care and Control in Bangladesh. Dr. Md. Nazrul Islam Program Manager NTP Bangladesh

Philippine Strategic TB Elimination Plan: Phase 1 (PhilSTEP1)

Engaging the Private Retail Pharmaceutical Sector in TB Case Finding in Tanzania: Pilot Dissemination Meeting Report

Republic of Indonesia

MANAGING AND MONITORING THE TB PROGRAMME

GLOBAL FUND ROUND 6 TB GRANT CLOSURE REPORT

Grant Aid Projects/Standard Indicator Reference (Health)

Assessment of the performance of TB surveillance in Indonesia main findings, key recommendations and associated investment plan

GUIDE: Reporting Template_Tuberculosis

Critical Appraisal of Tuberculosis Dots Diagnostic Centers in Lahore District

Standard operating procedures for the conduct of outreach training and supportive supervision

Systematic Engagement of Hospitals Philippine Experience. Dr. Marl Mantala 8 th PPM Sub-group Meeting, 10 Nov. 2012, Kuala Lumpur

Country experience on engaging large hospitals - INDIA

ENGAGE-TB. Operational Guidance M&E. Paris, 2 November ENGAGE-TB Operational Guidance November 2, 2013

Executive summary. 1. Background and organization of the meeting

Scaling up PPM: lessons from design and implementation of the Global Fund TB grants

PPM Subgroup Meeting: Lille

INTEGRATED CHRONIC DISEASE MANAGEMENT

FEDERAL MINISTRY OF HEALTH NATIONAL TUBERCULOSIS AND LEPROSY CONTROL PROGRAMME TERMS OF REFERENCE FOR ZONAL CONSULTANTS MARCH, 2017

The State Health & Family Welfare Society (RNTCP), NHM invites applications for the following contractual posts for a period of one year.

NATIONAL SITUATION ASSESSMENT

Performance of RNTCP NTI Bulletin 2003, 39 / 3&4, 19-23

Tuberculosis surveillance in Suriname. Drs. B. Jubithana, MD M. Wongsokarijo, MSc

Terms of Reference Kazakhstan Health Review of TB Control Program

Summary of the Evaluation Study

2012 TB Laboratory Specimen Referral, Reporting & Transportation for diagnosis and management of MDR TB (January to June 2012)

THE NATIONAL TUBERCULOSIS HEALTH SECTOR STRATEGIC PLAN FOR GHANA

Monitoring and Evaluation Plan for the National Tuberculosis Strategic Plan

Tuberculosis as an Occupational Disease. Molebogeng Malotle

IHF Training Manual for TB and MDR-TB Control for Hospital/Clinic/Health Facility Managers Executive Summary 2

TUBERCULOSIS CONTROL RESEARCH MATRIX

Changing the paradigm of Programmatic Management of Drug-resistant TB

Terms of Reference (TORs) and other job details are available on the department website cfw.ap.nic.in

Progress and plans on PPM in TB Control in South-East Asia Region. Dr Md Khurshid Alam Hyder Regional Adviser-TB WHO/SEARO

Fiduciary Arrangements for Grant Recipients

End-Term Comprehensive External Review of the Ghana National Tuberculosis Health Sector Strategic Plan

Hospital engagement lessons from the five-country WHO/CIDA initiative

Utilization of QI approaches to improve TB/HIV treatment outcomes in Swaziland

Strengthening and Aligning Diagnosis and Treatment of Drug Resistant TB in India

NEPAD Planning and Coordinating Agency. Southern Africa Tuberculosis and Health Systems Support Project Project ID: P155658

WHO Task Force Framework on assessment of surveillance data - Revisiting the "Onion model" Ana Bierrenbach WHO / STB /TME June 2010

Adherence with Evidence-based TB Standards and Guidelines in Selected Health Facilities in Kenya

THE GLOBAL FUND to Fight AIDS, Tuberculosis and Malaria

FAST. A Tuberculosis Infection Control Strategy. cough

Priority programmes and rural retention the example of TB. Karin Bergstrom Stop TB Department WHO, Geneva

FEDERAL MINISTRY OF HEALTH

Successful Practices to Increase Intermittent Preventive Treatment in Ghana

Extensive review of tuberculosis prevention, control and care in Armenia July 2014

Prevent the transmission of tuberculosis (TB) and cure individuals with active TB disease

Importance of the laboratory in TB control

Strengthening institutional capacity for nursing training on HIV/AIDS & Tuberculosis (GFATM R7) KNOWLEDGE, ATTITUDE & PRACTICES OF NURSES TOWARDS TB

Infection Control Care Plan for a patient with confirmed/ suspected Active Pulmonary Tuberculosis. Patient Demographic / Label

Tuberculosis Prevention and Control Protocol, 2018

National Tuberculosis Control Programme: Democratic People s Republic of Korea

Annex 2: Information Handouts

Measurement of TB Indicators using e-tb Manager (TB Patient Management Information System)

Procurement and supply management report for the WHO European Region, high MDR-TB priority countries, 2013

Prevent the transmission of tuberculosis (TB) and cure individuals with active TB disease

Sudan Ministry of Health Capacity Development Plan

Country: Democratic Republic ofcongo. Benjamin B.Nzailu

Engaging Private Drug Outlets in TB Case Finding: Tanzania Experience. Jumanne Marko Mkumbo Program Pharmacists Bangkok, March 2-6, 2015

Tuberculosis control

Improving the estimates of childhood TB disease burden and assessing childhood TB activities at country level

Patient Pathway Analysis: How-to Guide. Assessing the Alignment of TB Patient Care Seeking & TB Service Delivery

A survey of the views of civil society

BEST PRACTICE FOR THE CARE OF PATIENTS WITH TUBERCULOSIS

Management of patients with TB/HIV Gunta Kirvelaite

BUDGET REVISION FOR THE APPROVAL OF REGIONAL DIRECTOR

OPERATIONAL RESEARCH. What, Why and How? Dr. Rony Zachariah MD, PhD Operational Centre Brussels MSF- Luxembourg

WHO policy on TB infection control in health care facilities, congregate settings and households.

NORTHERN UGANDA MALARIA, HIV/AIDS AND TUBERCULOSIS (NUMAT) PROGRAMME LABORATORY PERFORMANCE MONITORING TOOL

ప క ప కటన స ఖ. దరఖ స ల న య త 5 గ.o., ల ప మ త అ దజ యవల న. ప వ లక న స ద చ. అభ ర ల దరఖ స ల న స య

REPORT OF THE NINTH MEETING

Toolkit to develop a national strategic plan for TB prevention, care and control

TB CARE I - Indonesia. Year 3. Annual Report. Period. October 1, 2012 September 30, 2013

Financial impact of TB illness

Survey Preparation prior to field operation in Cambodia

THE UNITED REPUBLIC OF TANZANIA REPORT OF THE REVIEW OF THE NATIONAL TUBERCULOSIS AND LEPROSY PROGRAMME IN TANZANIA JUNE 2000

Support, Capacity building and sustainability. Group (2)

SOURCE OF LATEST ANTI-TB TREATMENT AMONGST RE-TREATMENT TB CASES REGISTERED UNDER RNTCP IN GUJARAT

GOVERNMENT OF THE REPUBLIC OF SIERRA LEONE MINISTRY OF HEALTH AND SANITATION. National Infection Prevention and Control Policy

REQUIRED DOCUMENT FROM HIRING UNIT

ECSA 10 TH ANNUAL BEST PRACTICES FORUM 10 TH 12 TH APRIL 2017 MT. MERU HOTEL. Lab Managers Side Meeting

Senior Research, Measurement and Evaluation Officer (based in Abuja) Project: SIFPO/LEAP Project

Federal Ministry of Health

Nepal s National Tuberculosis Control Program

34th Board Meeting Mid-year 2015 Corporate KPI Results & 2016 Targets For Board Decision

KNOWLEDGE, ATTITUDE AND PRACTICE OF DOTS PROVIDERS UNDER RNTCP IN UJJAIN, MADHYA PRADESH

Monitoring & Evalua/on. Ari Probandari

Prevention and Care- Role of Pharmacists. Prafull Sheth, FIP Vice President

PhilHealth TB DOTS Out-patient Benefit Package

Business Coalitions- Mediators for TB care and control

Transcription:

GHANA HEALTH SERVICE MONITORING AND EVALUATION PLAN National tb control programme

Monitoring and evaluation plan for NTP INTRODUCTION The Health System Structure in Ghana The Health Service is organized into a three- tiered administrative system: national, regional and district levels but is five- tiered in terms of service delivery: national, regional, district, sub- district and Community Health Planning and Services (CHPS) zones. At the national level the Ghana Health Service is composed of ten main divisions. Each division has departments with responsibilities for carrying out the functions of the division. The NTP is a programme within the Disease Control and Prevention Department of the Public Health Division (one of the ten divisions). Implementation of key activities of the National Tuberculosis Programme (NTP) is organized within the 5- tier health system in Ghana. The Ministry of Health and its agencies, particularly the Ghana Health Service, are endowed with a countrywide network of health facilities (hospitals, health centres, clinics and maternity homes) distributed within the 10 regions and 170 districts of the country. Currently, there are 321 hospitals, 760 health centres, 1124 clinics and 601 medical laboratories manned by about a total workforce of 49,138. About 83% of all health facilities in Ghana belong to the public sector, 9% to faith- based institutions and 7% to the private sector. Health management in Ghana is fairly decentralized within the MOH involving District Health Management Teams (DHMTs), Regional Health Management Teams (RHMTs) and headquarters. Complimenting this arrangement are institutional/health facility management teams. Each of these management levels is a Budget and Management Centre i.e. they are responsible for a defined programme of work supported by a defined operational budget. The National TB control programme delivers its services within the Ministry s structures. The Central TB Unit (CTU) headed by a programme manager plays the leading role of overseeing TB control in Ghana. The CTU has a workforce of about 20 personnel inclusive of an M&E manager. The Central TB Unit spearheads the execution of the following responsibilities: advocacy and resource mobilization, providing technical leadership through the development of program policies and guidelines, planning, budgeting, supervising, monitoring and evaluation in addition 1

to building capacity for TB control. At the regional, district and institutional levels, implementation of the programme s activities are championed by coordinators who together with other health professionals form working teams. These TB teams are responsible for planning, budgeting, training and program monitoring through supportive supervision. Mandate, Goal and Objective of the NTP The mandate is to provide leadership for the health sector response to fight tuberculosis in Ghana. The goal is to reduce the burden of tuberculosis in Ghana until it is no longer a disease of public health importance. The overall objective of the NTP is to achieve the World Health Assembly (WHA), STOP TB Partnership and the Millennium Development Goal (MDG) targets of detecting at least 70% of incident smear positive TB cases and to half TB deaths by 2015 compared with the level in 1990. Presently, the NTP strategic approach is to provide universal access of TB control services to the entire population subsequently achieving a 100% case detection. The implementation of TB control services are adopted from the 6 STOP TB Strategies. Tuberculosis Situation in Ghana The NTP was established in 1994 and attained 100% DOTs coverage in 2005. The programme has progressively seen an increased number of cases over the years. In 1996 the reported number of TB cases was 7,425 and the number reported in 2009 is 15,286, the highest ever reported in a single year. Case notification rate is however still low at 64 per 100,000 population (Fig.1). There are regional variations in case notification with the Greater Accra Region recording the highest notification rate (82/100 000 population in 2009) and Northern Region recording the lowest notification rate of 24/100 000 population in the same year. 2

Figure 1: National Case notification In 2009, the NTP achieved treatment success rate of 85.3% which is slightly above WHO target of 85%. Treatment success rate however varied between regions. 5 out of 10 regions have already surpassed the 85% target. Figure 2 shows the trend of treatment success over the years. Fig.2 Treatment Success Rate 3

TB case fatality rate is high at 7.5% (Fig. 3) despite the low HIV prevalence (1.9%) in the general population. Regional fatality trends indicate high fatality rates of 12.5/100 000 population in 2008 in Upper East Region compared with 4.2/100 000 population in Volta Region the lowest in 2008. Figure 3: National Mortality Trend Ghana adopted the WHO interim policy on TB/HIV in 2005 and has been implementing most of the activities. A survey conducted in 2008 gave a TB/HIV point prevalence of 14.7%. Percentage of TB patients routinely screened for HIV increased from 40% in 2007 to 65% in 2009 (Fig.4). The percentage of HIV positive patient receiving Co- trimoxazole Preventive Therapy (CPT) reached the first ever highest peak in 2008 (87%). While percentage of HIV positive TB patients receiving anti- retroviral therapy (ART) is increasing but below 25%. 4

Fig 4: Proportion of TB patients screened for HIV Monitoring and Evaluation The NTP has a surveillance system that routinely captures data for outcomes measurement from both public and private institutions. The number of cases evaluated has improved markedly, rising from 38 percent in 1996 to 99.7 percent in 2007. The main weaknesses are manual nature of collecting and storage of data. Data analysis and use is relatively weak at operational levels. Baseline data, input, process, output, outcome and impact indicators are monitored using existing checklist outlined in the Health Sector Strategic Plan. In existence is a mechanism for quarterly reports from all levels of service delivery, twice yearly programmatic reviews with stakeholders, annual reviews linked to sector annual reviews with partners e.g. the health sector/partners mid- term and end of term evaluations. The NTP has adopted the new WHO recording and reporting system on TB control. While the NTP Central Unit has the technical capacities to appropriately manage the data on TB situation, these capacities are very weak at regional and district levels with resultant delays in data collection, compilation and dissemination. 5

Situation Analysis The Ghana NTP has sufficient funds for supervision at all levels. Supervisory checklists incorporating key indicators have been developed but are sometimes not used. Recording and reporting forms have been revised to incorporate HIV parameters and are currently being used. Gaps exist, particularly due to: Inadequate technical support to ensure good- quality supervision mainly from the Central Unit to the regions, the districts, and sub- districts Discrepancies of data submitted at the national level, as the data are not disaggregated according to district and facility Inadequate use of checklists at the regional and district levels Inappropriate filing system (information collected during monitoring, evaluation, and supervisory visits are kept on loose sheets of paper making that get mislaid and are therefore not available for examination) Supervisory visits limited in number and/or quality, especially in areas not fully benefiting from the Enablers Package TB registers and TB treatment card not filled in completely or containing inaccurate information, resulting in some patients having no unique district numbers Limited external technical assistance by partners Objectives of the M&E Plan General Objective The overall objective of the M&E plan is to measure the performance of the TB programme against the set goals and targets Specific Objectives To systematically monitor and measure program effectiveness To gather lessons from program implementation To identify problem areas and effect change through effective routine programme management at all levels To measure the impact of funding towards the achievement of programmatic goals 6

To assess progress towards achieving the TB related Millennium Development Goals Strategic Approach The M&E plan shall be implemented using the following strategies Biannual national review meetings of all stakeholders Regional quarterly review meetings District quarterly review meetings Routine and periodic Surveys Periodic Programme reviews Supportive supervisory visits at all levels Data reviews and validation Activities Conduct programme review meetings at national, region and district levels Conduct periodic surveys for TB prevalence, drug resistance, and KAP studies Undertake routine surveillance for TB: - Review data management system - Establish a database at the national- level for an electronic TB data information and management system - Train health staff at the sub- national level to use data management system - Review recording and reporting forms Conduct supervision visits at all levels and provide feedback Improve supervision capacity at all levels Undertake recruitment processes to fill human resources gaps where needed Support the activities of the TB Advisory Board and other technical working groups Develop, produce, and distribute NTP guidelines Procure vehicles to support supervision, monitoring and evaluation Support infrastructure enhancement (upgrade/renovate medical stores, wards, and DOTS centres) Procure TB Technical Assistance in support of M&E 7

The M&E Indicator Framework 8

Key M&E Indicators Number /percentage of new smear TB cases reported Number / percentage of all forms TB cases reported Number/percentage of new smear positive cured Number/ percentage of new smear positive cases successfully treated Number/ percentage of all forms of TB cured and successfully treated Number/ percentage of TB patients who died during treatment Number / percentage of TB patients tested for HIV and recorded in the register Number / percentage of TB patients on ART and recorded in the register Number / percentage of PLHIV at HIV clinic screened for TB Number / Percentage TB patients positive for HIV Number/ percentage of HIV positive TB patients who received CPT during TB treatment Number / percentage of previously treated TB patients detected with MDR- TB Number / percentage of MDR- TB in new TB patients Number / percentage of health facilities implement IPC plan Number / percentage of health workers developing TB Number/ percentage of TB cases reported from prisons Number/ percentage of TB cases reported from private sector Number/ percentage of advocacy materials produced Number/ percentage of operational research activities conducted with findings reported Number/ percentage of health workers trained on TB control 9

Definitions of Key Outcome Indicators Indicator Definition Numerator Denominator Case detection Number of new TB cases detected Number of new TB Estimated total rate (all forms) within a specified period expressed cases detected number of new TB as a proportion of the estimated within a specified cases total number of new TB cases period Countrywide within Countrywide the same period Case detection Number of new smear- positive TB Number of new Estimated number rate (Smear cases detected expressed as a smear- positive TB of new smear- positives) proportion of the estimated number of new smear- positive cases detected positive TB cases TB cases countrywide countrywide Treatment Number of new smear- positive Number of new Total number of success rate pulmonary TB cases registered in a smear- positive new smear- positive specified period that were cured pulmonary TB cases pulmonary TB cases plus the number that completed registered in a registered in the treatment expressed as a specified period that same period proportion of the Total number of were cured plus the new smear- positive pulmonary TB number that cases registered in the same completed treatment period Cure rate Number of new smear- positive Number of new Total number of pulmonary TB cases registered in a smear- positive new smear- positive specified period that were cured pulmonary TB cases pulmonary TB cases expressed as a proportion of the registered in a registered in the total number of new smear- specified period that same period positive pulmonary TB cases were cured registered in the same period Case notification Number of new TB cases reported Number of new TB Total population in rate (* 100,000) expressed as cases reported the specified area proportion of the total population (* 100,000) in the specified area 10

Mortality rate Number of new smear- positive Number of new Total number of pulmonary TB cases registered in a smear- positive new smear- positive specified period that died during pulmonary TB cases pulmonary TB cases treatment, irrespective of cause registered in a registered in the expressed as a proportion of the specified period that same period total number of new smear- died during positive pulmonary TB cases treatment, registered in the same period irrespective of cause Number Number of new smear positive TB Number of new Total number of /percentage of cases registered during a specified smear positive TB new pulmonary TB new smear period expressed as a proportion cases registered cases registered positive TB cases of the total number of new during a specified during the same reported pulmonary TB cases registered period period during the same period Number / Number of adults and children Number of adults Total number of percentage of enrolled in HIV care whose TB and children enrolled adults and children PLHIV at HIV clinic status was assessed and recorded in HIV care whose TB enrolled in HIV care screened for TB during their last visit during the status was assessed and seen for care in Reporting period, expressed as a and recorded during the reporting period proportion of all adults and their last visit during children enrolled in the reporting period HIV care and seen for care in the reporting period Number / Percentage of TB patients who had Number of TB Total number of TB percentage of TB an HIV test result recorded in the patients registered patients registered patients tested for TB register during the reporting during the reporting HIV and recorded period who had an period in the register HIV test result11 recorded in the TB register Number / Number of registered TB patients Total number of all Total number of TB Percentage TB with documented HIV status on TB TB patients patients registered 11

patients positive register who are HIV- positive, registered over the during the reporting for HIV expressed as a proportion of the reporting period period with total number of all registered TB with documented documented HIV patients with documented HIV HIV- positive status status status over the reporting period Number / Number of HIV- positive TB patients All HIV- positive TB Total number of percentage of TB who are started on or continue patients, registered HIV- positive TB patients on ART previously initiated ART during TB over the reporting patients registered and recorded in treatment, expressed as a period, who receive during the reporting the register proportion of all HIV- positive TB ART (are started on period patients. registered over the or continue reporting period previously initiated ART). Number/ Number of HIV- positive TB patients Number of HIV- Total number of percentage of HIV who are started on or continue positive TB patients, HIV- positive TB positive TB previously initiated CPT, during TB registered over the patients registered patients who treatment, expressed as a reporting period, during the reporting received CPT proportion of all HIV- positive TB starting or continuing period during TB patients registered over the CPT treatment during treatment reporting period their TB treatment Source of data for indicators Clients cards Institutional registers Monthly/ quarterly surveillance reports Review reports/ survey reports Supervisory reports 12

SUPERVISORY CHECKLIST FOR TB PROGRAMME AT DISTRICT HEALTH MANAGEMENT LEVEL INSTRUCTION: (FILL, TICK OR CIRCLE as appropriate) SECTION A Name of Supervisor(s): Date of Visit: District/Region: Date of last supervisory visit: Is feedback report available? Yes / No By Who: State the key challenges identified in last quarter s feedback reports and indicated whether they have been addressed or not? SECTION B: TB CONTROL ACTIVITIES Milestones Milestone template available Yes No Milestone report submitted for the last quarter Yes No Was district able to achieve all milestone targets? Yes No If not, state challenges Finances Finances has been received from the Programme this quarter for TB Control Yes No activities Action plan has been drawn to implement activities for this quarter Yes No Financial and activity reports available showing the use of funds Yes No received from the Programme last quarter Enablers package disbursed according to NTP guidelines Yes No 13

Review Meetings Supervision Was there a TB programme review meeting held last quarter Yes No Is the minutes/report available? Yes No Number of sub-district/facilities supervised last quarter Feedback reports on supervision available? Yes No Training The district has a database of health staff trained in TB Yes No Last quarter training reports are available Yes No Has the district conducted training needs assessment? Yes No If yes, list any challenges identified and if possible ways the district is strategizing to address these Renovations The district has structure(s) earmarked for renovation Yes No If yes, what structures and the level of completion? CB DOTS PPM DOTS TB in Prisons NGOs No. of districts implementing CB DOTS out of districts No. of treatment supporters trained ; No. functional Monitoring of home-based TB care activities is done Yes No Community TB register is in use Yes No Number of Private Clinics in the districts implementing TB control activities No. of TB patients notified by the private sector out of patients last quarter Do you have a prison facility in your district? Yes No When was the last time prison inmates and staff were screened for TB Is the screening outcome available? Yes No No. of NGOs working in the district on TB Name of NGOs What are the areas of intervention? ACSM Activities What ACSM activities were carried out last quarter? ACSM Activities Are the reports available? Yes No What ACSM activities are planned for this quarter and the level of implementation? 14

Remarks / Explanation Recommendations 15

SUPERVISORY CHECKLIST FOR TB PROGRAMME AT HEALTH FACILITY LEVEL INSTRUCTION: (FILL, TICK OR CIRCLE as appropriate) SECTION A Name of Supervisor(s): Date of Visit: Facility Name: District/Region: Date of last supervisory visit by Dist TB Coordinator: Is feedback report available? Yes / No Date of last supervisory visit by Reg TB Coordinator: Is feedback report available? Yes / No State the key challenges identified in last quarter s feedback reports and indicated whether they have been addressed or not? Challenge Status/Comment 16

SECTION A: RECORDING AND REPORTING OF TB ACTIVITIES a. Client Card TB01 (Check records of at least 10 randomly selected patients) Sputum examination result form is kept and attached to the client Yes No card (TB01) Patients are classified correctly in client cards (TB01) Yes No Patients are put on the right treatment category for patient type and Yes No weight List all other deficiencies found below: b. Institutional TB Register All patients on treatment are recorded in the institutional register Yes No The institutional registers are completely and accurately filled Yes No Patient have follow-up sputum examinations at recommended Yes No interval Are TB cases that are positive at the end of intensive phase given 1 Yes No extra month of intensive phase medicines? Are failure cases at the end of month 5 or more given retreatment Yes No regimen? List all other deficiencies found: c. Case Holding d. ADR Forms Defaulter Retrieval System is in place? Yes No If yes, there was defaulting patient(s) last quarter of which was/were retrieved Adverse drug reaction forms are available and staff knows how to fill Yes No forms SECTION B: TB.HIV COLLABORATIVE ACTIVITIES a. TB Clinic DOTS Centre staff trained in HIV Counseling and Testing Yes No DOTS Centre staff offers on-site HIV counseling and testing Yes No services to TB patients TB/HIV Collaborative activities are well documented in TB01 Yes No and institutional register b. HIV TB Screening tool is available at the HIV Clinic Yes No Clinic All HIV patients are screened for TB Yes No 17

SECTION C: LOGISTICS a. Is there a staff designated for managing TB drugs Yes No Pharmacy/ If yes, has the staff been trained on LMIS for TB medicines? Yes No Stores The staff has the skills and knowledge to counsel patients on TB Yes No drugs The place is adequate for storage of drugs (spacious, ventilated, Yes No waterproof and protected from direct sunlight) b. TB RRIRV was filled and submitted for drugs in the last review Yes No Logistics Status period Physical count of all TB drugs tallies with balances on bin cards Yes No There was a stock-out of TB drugs within the last 3 months Yes No There is a lab staff in charge of monitoring stock levels of TB Yes No laboratory consumables and making requisitions Requisition for lab supplies was made in the last review period Yes No All laboratory supplies are available and enough to last for 3 months* Yes No There was a stock-out of TB lab supplies within the last 3 months Yes No TB recording/reporting materials are enough to last for 3 months Yes No * see annex 1 to determine adequacy of lab supplies LOGISTICS No Item Unit Balance on Tally card TB Drugs 1. Category I Kit 2 Category II Kit 3. Category III Kit 4. 5. 6. 7. 8. Physical count Difference Expiry date Remark No Item Unit Quantity Utilized last quarter Laboratory Supplies for TB microscopy 1. Carbol fuchsin ml Solution 2. Decolorizer ml 3. Counterstain ml (Methylene Blue) Quantity Available Expiry Date Remark 18

4. 95% Alcohol ml 5. Immersion oil ml 6. Slides pcs 7. Sputum container pcs 8. Sulphuric Acid ml 9. 10. 11. 12. D. LABORATORY SERVICES a. Workplace The laboratory has a well ventilated place designated for the performance of sputum smear microscopy The workplace is adequate for performance of sputum smear microscopy (sink, water, work bench available) Personnel Lab has personnel trained to perform sputum smear microscopy Yes No b.laboratory Register TB laboratory register is neat, completely and correctly filled Yes No Red ink is used to indicate positive results Yes No List all other deficiencies found; Yes Yes No No c. Equipment The microscope is in good working condition Yes No If not, what is wrong? (fungal growth on lens; x100 objective lens not functional, lamp not functional etc) d. Specimen collection e. Storage of Slides Specimens are collected with NTP approved containers Yes No The container is labeled with full details before it is handed to Yes No the patient TB Request form for Sputum examination is filled correctly Yes No 3 sputum specimens are examined Yes No Patients are told to take a deep breath before coughing out Yes No sputum Turnaround time for sputum microscopy is 72hours Yes No There is a functional system for tracing TB suspects who do not Yes No pick up sputum results If yes, TB suspects were traced last quarter out of Slides are stored in slide boxes for quality assurance Yes No If not, what are the challenges? 19

Remarks / Explanation Recommendations Annex 1 Laboratory Supplies for TB Microscopy Item Quantity Needed per Smear (a) Decolorizing Solution 5ml Counterstain Solution (Methylene Blue) 5ml Phenolic Fuchsin Solution 5ml Sputum Containers 1 Slides 1 Immersion Oil 0.1ml Xylene 0.1ml Number of Smears Done Last Quarter (b) Total Number of Supplies Needed for New Quarter (a X b) 20